SEC Form 4 · accession 0001209191-15-083818
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roberto Pedro Rosenkranz
Director
Period of report
Dec 4, 2015
Accepted (ET)
Dec 7, 2015 · 6:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 4, 2015 | M | 4,000 | $2.90 | A | 39,000 | D | |
| Common Stock | Dec 4, 2015 | M | 3,000 | $5.95 | A | 42,000 | D | |
| Common Stock | holding | — | — | — | 40 | I | By spouse as custodian for daughter |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.90 | Dec 4, 2015 | M | 4,000 | D | — | Apr 27, 2020 | Common Stock | 4,000 | 0 | D |
| Stock Option (Right to Buy)F1 | $5.95 | Dec 4, 2015 | M | 3,000 | D | — | Jun 27, 2022 | Common Stock | 3,000 | 0 | D |
Explanation of responses
- F1Fully vested.